Literature DB >> 27056778

Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan.

Taku Inohara1, Shun Kohsaka2, Hiroaki Miyata3, Ikuko Ueda4, Yuichiro Maekawa4, Keiichi Fukuda4, David J Cohen5, Kevin F Kennedy5, John S Rumsfeld6, John A Spertus5.   

Abstract

BACKGROUND: Stratifying patient risk for acute kidney injury (AKI) prior to percutaneous coronary intervention (PCI) can enable clinicians to tailor their approach to minimize AKI. The National Cardiovascular Data Registry (NCDR) CathPCI Registry recently developed 2 prediction models: for AKI and AKI requiring dialysis (AKI-D).
OBJECTIVES: This study sought to externally validate the NCDR AKI and AKI-D models in a Japanese population. Determining the generalizability of the U.S. model could support quality improvement efforts in Japan.
METHODS: The NCDR prediction models were applied to 11,041 consecutive patients in the Japanese multicenter PCI registry. AKI was defined as an absolute increase ≥ 0.3 mg/dl or a relative increase of 50% in serum creatinine, in accordance with the definition of AKI Network criteria; AKI-D was defined as initiation of dialysis after PCI. Discrimination and calibration of the NCDR models were tested in the Japanese cohort. If the model was perfectly calibrated, the slope and intercept would equal 1.0 and 0.0, respectively.
RESULTS: In the Japanese PCI cohort, AKI and AKI-D occurred in 10.5% and 1.5% of patients, respectively. The NCDR AKI prediction model showed good discrimination (c-statistic = 0.76) and calibration (slope = 0.93 and intercept = -0.10) in both acute and nonacute PCI. The AKI-D prediction model had good discrimination (c-statistic = 0.92), but while the calibration slope was good (1.04), the intercept was significantly underestimated (0.96). However, this was corrected with recalibration (slope = 1.04 and intercept = -0.087).
CONCLUSIONS: In a Japanese population, the NCDR AKI models validly predict post-procedural AKI and, with recalibration, AKI-D. Prospective use of these models to inform clinical decision making should be tested as a means of reducing AKI after PCI in Japan. (Japan Cardiovascular Database, Percutaneous Coronary Intervention Registry; UMIN R000004736).
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  external validation; percutaneous coronary intervention; risk model; serum creatinine

Mesh:

Substances:

Year:  2016        PMID: 27056778     DOI: 10.1016/j.jacc.2016.01.049

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

2.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

Review 3.  International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives.

Authors:  Jonathan C Hsu; Masaharu Akao; Mitsuru Abe; Karen L Anderson; Alvaro Avezum; Nathan Glusenkamp; Shun Kohsaka; Deirdre A Lane; Gregory Y H Lip; Chang-Sheng Ma; Frederick A Masoudi; Tatjana S Potpara; Teo Wee Siong; Mintu P Turakhia; Hung-Fat Tse; John S Rumsfeld; Thomas M Maddox
Journal:  J Am Heart Assoc       Date:  2016-11-02       Impact factor: 5.501

4.  Effects of body habitus on contrast-induced acute kidney injury after percutaneous coronary intervention.

Authors:  Toshiki Kuno; Yohei Numasawa; Mitsuaki Sawano; Toshiomi Katsuki; Masaki Kodaira; Ikuko Ueda; Masahiro Suzuki; Shigetaka Noma; Koji Negishi; Shiro Ishikawa; Hiroaki Miyata; Keiichi Fukuda; Shun Kohsaka
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

5.  Risk stratification model for in-hospital death in patients undergoing percutaneous coronary intervention: a nationwide retrospective cohort study in Japan.

Authors:  Taku Inohara; Shun Kohsaka; Kyohei Yamaji; Hideki Ishii; Tetsuya Amano; Shiro Uemura; Kazushige Kadota; Hiraku Kumamaru; Hiroaki Miyata; Masato Nakamura
Journal:  BMJ Open       Date:  2019-05-22       Impact factor: 2.692

6.  Outcome of Percutaneous Coronary Intervention in Relation to the Institutional Volume of Coronary Artery Bypass Surgery.

Authors:  Shun Kohsaka; Hiraku Kumamaru; Taku Inohara; Tetsuya Amano; Takashi Akasaka; Hiroaki Miyata; Noboru Motomura; Masato Nakamura
Journal:  J Clin Med       Date:  2020-04-27       Impact factor: 4.241

7.  Machine learning prediction model of acute kidney injury after percutaneous coronary intervention.

Authors:  Toshiki Kuno; Takahisa Mikami; Yuki Sahashi; Yohei Numasawa; Masahiro Suzuki; Shigetaka Noma; Keiichi Fukuda; Shun Kohsaka
Journal:  Sci Rep       Date:  2022-01-14       Impact factor: 4.996

8.  Prognostic Impact of Subsequent Acute Coronary Syndrome and Unplanned Revascularization on Long-Term Mortality After an Index Percutaneous Coronary Intervention: A Report From a Japanese Multicenter Registry.

Authors:  Taku Inohara; Shun Kohsaka; Hiroaki Miyata; Mitsuaki Sawano; Ikuko Ueda; Yuichiro Maekawa; Keiichi Fukuda; Philip G Jones; David J Cohen; Zhenxiang Zhao; John A Spertus; Kim G Smolderen
Journal:  J Am Heart Assoc       Date:  2017-10-27       Impact factor: 5.501

9.  Exploring Triaging and Short-Term Outcomes of Early Invasive Strategy in Non-ST Segment Elevation Acute Coronary Syndrome: A Report from Japanese Multicenter Registry.

Authors:  Nobuhiro Ikemura; Yasuyuki Shiraishi; Mitsuaki Sawano; Ikuko Ueda; Yohei Numasawa; Shigetaka Noma; Masahiro Suzuki; Yukihiko Momiyama; Kentaro Hayashida; Shinsuke Yuasa; Hiroaki Miyata; Keiichi Fukuda; Shun Kohsaka
Journal:  J Clin Med       Date:  2020-04-13       Impact factor: 4.241

10.  Evidence-to-Practice Gap for Preventing Procedure-Related Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Satoshi Shoji; Mitsuaki Sawano; Alexander T Sandhu; Paul A Heidenreich; Yasuyuki Shiraishi; Shigetaka Noma; Masahiro Suzuki; Yohei Numasawa; Keiichi Fukuda; Shun Kohsaka
Journal:  J Am Heart Assoc       Date:  2021-07-26       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.